RM
+
Lenvima cancer medication
RM
+
Lenvima cancer medication
RM
+
Insulin receptor molecule illustration
RF
+
Raf-MEK-ERK pathway illustration
RF
+
Illustration of a cell membrane showing the proteins involved in the Raf-MEK-ERK or MAPKERK pathway The signal cascade begins when epidermal growt
RM
+
Insulin receptor molecule illustration
RM
+
Illustration of an insulin receptor as a glass surface model with indicated deeper ribbon model on a dark background Insulin receptors are located in
RM
+
Illustration of an insulin receptor as a glass surface model with indicated deeper ribbon model on a white background Insulin receptors are located i
RM
+
Tivozanib kidney cancer drug Capsule of the kidney cancer drug tivozanib marketed under the name Fotivda Tivozanib is an oral VEGF receptor tyrosin
ED
+
Glivec chemotherapy drug Computer model of a molecule of the chemotherapy drug Glivec Atoms are represented as spheres and are colour-coded carbon
RF
+
Epidermal growth factor receptor illustration
RF
+
Epidermal growth factor and receptor complex illustration
RF
+
Epidermal growth factor and receptor complex illustration
RF
+
Epidermal growth factor molecules illustration
RM
+
EGFR Receptor inactivated by Afatinib illustration
RM
+
Illustration of the dimer of the intracellular domain of the epidermal growth factor receptor (EGFR) which contains a tyrosine kinase (blue) The kin
RM
+
Osimertinib anti-cancer drug
RM
+
Osimertinib anti-cancer drug
RM
+
Osimertinib anti-cancer drug
ED
+
Cancer protein Computer model of the enzyme protein tyrosine kinase which is involved in cancer cell formation This is a subject of study by the ca
RM
+
Osimertinib anti-cancer drug
RM
+
Osimertinib anti-cancer drug
RF
+
Vascular endothelial growth factor receptor illustration
RF
+
Active insulin receptors illustration
RF
+
Active insulin receptor illustration
RM
+
Insulin receptor illustration
RM
+
Insulin receptor illustration The insulin receptor (blue) is a transmembrane protein that becomes activated through the binding of insulin (orange)
RM
+
Nilotinib cancer drug molecule
RM
+
Nilotinib cancer drug molecular model Ball-and-stick model of the cancer drug nilotinib (C28H22F3N7O) Nilotinib is a drug used for the treatme
RM
+
Dasatinib cancer drug molecule
RM
+
Dasatinib cancer drug molecule
RM
+
Nilotinib cancer drug molecular model Space-filled molecular model of the cancer drug nilotinib (C28H22F3N7O) Nilotinib is a drug used for the
RM
+
Nilotinib cancer drug molecule
RM
+
Dasatinib cancer drug molecule
RM
+
Dasatinib cancer drug molecular molecule Ball-and-stick molecular model of the cancer drug dasatinib (C22H26ClN7O2S) This oral cancer medicat
RM
+
Ricin complexed with antibody V5G6 molecular model
RM
+
Ricin complexed with antibody V5G6 molecular model
RM
+
Pelitinib drug molecular model
RM
+
Molecular model of the drug Pelitinib (C24H23ClFN5O2) Pelitinib is a tyrosine kinase inhibitor that has been shown to bind covalently to the SAR
RF
+
Zanubrutinib cancer drug molecule illustration Atoms are represented as spheres with conventional colour coding hydrogen (white) carbon (black) n
RF
+
Tolebrutinib multiple sclerosis drug molecule illustration
RF
+
Tolebrutinib multiple sclerosis drug molecule illustration Atoms are represented as spheres with conventional colour coding hydrogen (white) carbo
RF
+
Tolebrutinib multiple sclerosis drug molecule illustration Skeletal formula Photo by MOLEKUULSCIENCE PHOTO LIBRARY
RF
+
Tolebrutinib multiple sclerosis drug molecule illustration Skeletal formula Photo by MOLEKUULSCIENCE PHOTO LIBRARY
RF
+
Surufatinib cancer drug molecule illustration
RF
+
Rilzabrutinib drug molecule illustration Atoms are represented as spheres with conventional colour coding hydrogen (white) carbon (black) nitroge
RF
+
Rilzabrutinib drug molecule illustration
RF
+
Rilzabrutinib drug molecule illustration Skeletal formula Photo by MOLEKUULSCIENCE PHOTO LIBRARY
RF
+
Rilzabrutinib drug molecule illustration Skeletal formula Photo by MOLEKUULSCIENCE PHOTO LIBRARY
RF
+
Pralsetinib cancer drug molecule illustration
RF
+
Pralsetinib cancer drug molecule illustration Atoms are represented as spheres with conventional colour coding hydrogen (white) carbon (grey) nit
RF
+
Pralsetinib cancer drug molecule illustration Skeletal formula Photo by MOLEKUULSCIENCE PHOTO LIBRARY
RF
+
Pralsetinib cancer drug molecule illustration
RF
+
Evobrutinib drug molecule illustration
RF
+
Evobrutinib drug molecule illustration
RF
+
Evobrutinib drug molecule illustration
RF
+
Evobrutinib drug molecule illustration Skeletal formula Photo by MOLEKUULSCIENCE PHOTO LIBRARY
RF
+
Fenebrutinib drug molecule illustration
RF
+
Fenebrutinib drug molecule illustration Atoms are represented as spheres with conventional colour coding hydrogen (white) carbon (black) nitrogen
RF
+
Fenebrutinib drug molecule illustration
RF
+
Fenebrutinib drug molecule illustration
RF
+
Cediranib cancer drug molecule illustration Atoms are represented as spheres with conventional colour coding hydrogen (white) carbon (black) nitr
RF
+
Capmatinib cancer drug molecule (c-met inhibitor) illustration Atoms are represented as spheres with conventional colour coding hydrogen (white) c
RF
+
Entrectinib cancer drug molecule illustration
RM
+
Cytoplasmic tyrosine kinase ZAP-70 molecular model
RM
+
Tyrosine kinase c-Abl
RM
+
Tyrosine kinase c-Abl
RM
+
Nilotinib Molecular model of the cancer drug nilotinib (C28
RM
+
Dasatinib Molecular model of the cancer drug dasatinib (C22H26ClN7O2S) This medication sold under the name Sprycel is a tyrosine kinase inhibit
RM
+
Receptor tyrosine kinase Torso complex
RM
+
Receptor tyrosine kinase Torso complex Computer model showing the structure of silkworm receptor tyrosine kinase Torso (blue green) complexed with p
RM
+
Tyrosine kinase c-Abl
RM
+
Tyrosine kinase c-Abl
RM
+
Growth factor receptor complex
RM
+
Growth factor receptor complex
RM
+
Tyrosine kinase of an insulin receptor
RM
+
Tyrosine kinase of an insulin receptor
RM
+
Zika virus and stem cells illustration
RM
+
Zika virus and AXL receptor Computer illustration of a Zika virus (ZIKV) particle (spherical) attached to an AXL receptor on the surface of a neural
RM
+
Tyrosine kinase and bosutinib complex Computer illustration showing a molecule of bosutinib (spheres) bound to a tyrosine kinase molecule (grey) Tyr
RM
+
Tyrosine kinase and bosutinib complex Computer illustration showing a molecule of bosutinib (spheres) bound to a tyrosine kinase molecule (ribbons)
RM
+
Tyrosine kinase and bosutinib complex
RM
+
Osimertinib lung cancer drug molecule
RM
+
Osimertinib lung cancer drug molecule Computer model showing the structure of a molecule of the epidermal growth factor receptor (EGFR) tyrosine kina
RM
+
Sunitinib molecule
RM
+
Lapatinib drug molecule
RM
+
Gefitinib Molecular model of the chemotherapy drug gefitinib (C22H24ClFN4O3) used in the treatment of certain breast lung and other cancers I
RM
+
Molecular model of the tyrosine kinase haemopoietic cell kinase (hck) complexed with the flavanoid quercetin
RM
+
Kinase complexed with quercetin
RM
+
Src protein molecule
RM
+
Src protein molecular model Src is a tyrosine kinase a signalling protein in cells that has the ability to turn on protein synthesis and cellular
RM
+
On the right insulin binds with its receptor in a normal manner This brings the glucose transporter (Glut-4) to the plasma membrane allowing glucos
RM
+
Lenvima cancer medication
RM
+
Lenvima cancer medication
RM
+
Insulin receptor molecule illustration
RF
+
Raf-MEK-ERK pathway illustration
RF
+
Illustration of a cell membrane showing the proteins involved in the Raf-MEK-ERK or MAPKERK pathway The signal cascade begins when epidermal growt
RM
+
Insulin receptor molecule illustration
RM
+
Illustration of an insulin receptor as a glass surface model with indicated deeper ribbon model on a dark background Insulin receptors are located in
RM
+
Illustration of an insulin receptor as a glass surface model with indicated deeper ribbon model on a white background Insulin receptors are located i
368
0
https://www.afloimages.com/search/tyrosine%20kinase.html